Journal
JOURNAL OF IMMUNOLOGY
Volume 176, Issue 11, Pages 6752-6761Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.176.11.6752
Keywords
-
Categories
Ask authors/readers for more resources
Tryptophan catabolism is a tolerogenic effector system in regulatory T cell function, yet the general mechanisms whereby tryptophan catabolism affects T cell responses remain unclear. We provide evidence that the short-term, combined effects of tryptophan deprivation and tryptophan catabolites result in GCN2 kinase-dependent down-regulation of the TCR zeta-chain in murine CD8(+) T cells. TCR C down-regulation can be demonstrated in vivo and is associated with an impaired cytotoxic effector function in vitro. The longer-term effects of tryptophan catabolism include the emergence of a regulatory phenotype in naive CD4(+)CD25(-) T cells via TGF-beta induction of the forkhead transcription factor Foxp3. Such converted cells appear to be CD25(+), CD69(-), CD45RB(low), CD62L(+), CTLA-4(+), BTLA(low) and GITR(+), and are capable of effective control of diabetogenic T cells when transferred in vivo. Thus, both tryptophan starvation and tryptophan catabolites contribute to establishing a regulatory environment affecting CD8(+) as well as CD4(+) T cell function, and not only is tryptophan catabolism an effector mechanism of tolerance, but it also results in GCN2-dependent generation of autoimmune-preventive regulatory T cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available